SENORES — Senores Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹25.67bn
- IN₹28.82bn
- IN₹3.98bn
- 21
- 17
- 87
- 34
Annual cashflow statement for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 11.4 | 124 | 249 | 706 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | -0.43 | 6.72 | -0.7 | -77.9 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -123 | -160 | -602 | -1,255 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -104 | -10.8 | -252 | -459 |
| Capital Expenditures | -107 | -473 | -518 | -1,575 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -138 | -10.1 | -24 | -2,720 |
| Acquisition of Business | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -244 | -483 | -542 | -4,295 |
| Financing Cash Flow Items | 211 | -14.1 | -98.5 | 4,358 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 365 | 463 | 870 | 5,731 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 15.8 | -31.1 | 75.5 | 977 |